Here's Why We're Watching Decibel Therapeutics' (NASDAQ:DBTX) Cash Burn Situation




  • In Business
  • 2022-08-13 14:34:11Z
  • By Simply Wall St.
 

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt.

So, the natural question for Decibel Therapeutics (NASDAQ:DBTX) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of money a company spends each year to fund its growth. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.

See our latest analysis for Decibel Therapeutics

Does Decibel Therapeutics Have A Long Cash Runway?

A company's cash runway is calculated by dividing its cash hoard by its cash burn. In June 2022, Decibel Therapeutics had US$126m in cash, and was debt-free. Importantly, its cash burn was US$57m over the trailing twelve months. So it had a cash runway of about 2.2 years from June 2022. That's decent, giving the company a couple years to develop its business. You can see how its cash balance has changed over time in the image below.

How Is Decibel Therapeutics' Cash Burn Changing Over Time?

Because Decibel Therapeutics isn't currently generating revenue, we consider it an early-stage business. Nonetheless, we can still examine its cash burn trajectory as part of our assessment of its cash burn situation. During the last twelve months, its cash burn actually ramped up 64%. While this spending increase is no doubt intended to drive growth, if the trend continues the company's cash runway will shrink very quickly. Clearly, however, the crucial factor is whether the company will grow its business going forward. So you might want to take a peek at how much the company is expected to grow in the next few years.

How Hard Would It Be For Decibel Therapeutics To Raise More Cash For Growth?

Given its cash burn trajectory, Decibel Therapeutics shareholders may wish to consider how easily it could raise more cash, despite its solid cash runway. Issuing new shares, or taking on debt, are the most common ways for a listed company to raise more money for its business. Commonly, a business will sell new shares in itself to raise cash and drive growth. By comparing a company's annual cash burn to its total market capitalisation, we can estimate roughly how many shares it would have to issue in order to run the company for another year (at the same burn rate).

Decibel Therapeutics has a market capitalisation of US$108m and burnt through US$57m last year, which is 53% of the company's market value. That's high expenditure relative to the value of the entire company, so if it does have to issue shares to fund more growth, that could end up really hurting shareholders returns (through significant dilution).

So, Should We Worry About Decibel Therapeutics' Cash Burn?

Even though its cash burn relative to its market cap makes us a little nervous, we are compelled to mention that we thought Decibel Therapeutics' cash runway was relatively promising. Even though we don't think it has a problem with its cash burn, the analysis we've done in this article does suggest that shareholders should give some careful thought to the potential cost of raising more money in the future. Separately, we looked at different risks affecting the company and spotted 4 warning signs for Decibel Therapeutics (of which 3 don't sit too well with us!) you should know about.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies, and this list of stocks growth stocks (according to analyst forecasts)

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You'll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

COMMENTS

More Related News

We
We're Hopeful That Quadrise Fuels International (LON:QFI) Will Use Its Cash Wisely

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Kingsrose Mining (ASX:KRM) Is In A Good Position To Deliver On Growth Plans
Kingsrose Mining (ASX:KRM) Is In A Good Position To Deliver On Growth Plans

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Here
Here's Why We're Not Too Worried About Libertine Holdings' (LON:LIB) Cash Burn Situation

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

An Intrinsic Calculation For KBR, Inc. (NYSE:KBR) Suggests It
An Intrinsic Calculation For KBR, Inc. (NYSE:KBR) Suggests It's 48% Undervalued

Today we will run through one way of estimating the intrinsic value of KBR, Inc. ( NYSE:KBR ) by taking the expected...

Is Evolution Energy Minerals (ASX:EV1) In A Good Position To Deliver On Growth Plans?
Is Evolution Energy Minerals (ASX:EV1) In A Good Position To Deliver On Growth Plans?

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business